4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-22-021377
Options or other derivatives
- President and CEO acquired 1,156,913 shares (grant or award)
- President and CEO returned 1,156,913 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Lucchino David L. · President and CEO
Table II: Derivative
6 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2022-08-17 | Grant or award : show line 1 in the form Stock Option | +714,413 | $2.14 | 2029-10-01 | 714,413 | 714,413 | D |
| 2022-08-17 | Returned to the company : show line 2 in the form Stock Option | −714,413 | $14.00 | 2029-10-01 | 714,413 | 0 | D |
| 2022-08-17 | Grant or award : show line 3 in the form Stock Option | +242,500 | $2.14 | 2030-02-11 | 242,500 | 242,500 | D |
| 2022-08-17 | Returned to the company : show line 4 in the form Stock Option | −242,500 | $25.05 | 2030-02-11 | 242,500 | 0 | D |
| 2022-08-17 | Grant or award : show line 5 in the form Stock Option | +200,000 | $2.14 | 2031-01-14 | 200,000 | 200,000 | D |
| 2022-08-17 | Returned to the company : show line 6 in the form Stock Option | −200,000 | $35.85 | 2031-01-14 | 200,000 | 0 | D |
Loading xslF345X03/form4.xml…